Every Cure Partners with OpenEvidence to Advance Noncommercial Drug Repurposing
This story is from 2026-11-16. It is preserved in the archive; the latest stories are on the live feed.
On November 16, 2026, Every Cure announced a partnership with OpenEvidence to advance new uses for existing medicines where commercial incentives are lacking, linking AI-supported drug evaluation with repurposing efforts.
Read the full story at Unite.AI ↗
Timeline · 1 report
- 2026-11-16 19:21 · Unite.AI
Every Cure Taps OpenEvidence to Advance Noncommercial Drug Repurposing